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Ferroportin exports iron into plasma from absorptive
enterocytes, erythrophagocytosing macrophages,
and hepatic stores. The hormone hepcidin controls
cellular iron export and plasma iron concentrations
by binding to ferroportin and causing its internaliza-
tion and degradation. We explored the mechanism
of hepcidin-induced endocytosis of ferroportin, the
key molecular event in systemic iron homeostasis.
Hepcidin binding caused rapid ubiquitination of fer-
roportin in cell lines overexpressing ferroportin and
in murine bone marrow-derived macrophages. No
hepcidin-dependent ubiquitination was observed in
C326S ferroportinmutant which does not bind hepci-
din. Substitutions of lysines between residues 229
and 269 in the third cytoplasmic loop of ferroportin
prevented hepcidin-dependent ubiquitination and
endocytosis of ferroportin, and promoted cellular
iron export even in the presence of hepcidin. The
human ferroportin mutation K240E, previously asso-
ciated with clinical iron overload, caused hepcidin
resistance in vitro by interfering with ferroportin
ubiquitination. Our study demonstrates that ubiquiti-
nation is the functionally relevant signal for hepcidin-
induced ferroportin endocytosis.
INTRODUCTION
Hepcidin-induced ferroportin internalization is a critical event in
iron homeostasis. Ferroportin (Fpn) is a conserved iron exporter
expressed in tissues supplying iron to plasma, including
duodenal enterocytes absorbing dietary iron and macrophages
recycling iron from old erythrocytes (Donovan et al., 2005). The
rate of iron export is determined by the concentration of Fpn
on the plasma membranes of iron-exporting cells. Hepcidin
binds to Fpn and causes its endocytosis and degradation,
thereby regulating iron efflux (Nemeth et al., 2004). Alterations
in hepcidin or Fpn production, or in their interaction, cause iron918 Cell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc.overload diseases and iron-restricted anemias (Ganz and Nem-
eth, 2011). The mechanism by which hepcidin induces Fpn
endocytosis is therefore of great interest not only as fundamental
iron physiology but also for developing drug leads.
In general, ligand-induced endocytosis of transporters and
receptors is triggered by a conformational change followed by
phosphorylation and/or ubiquitination of their cytoplasmic
segments (Bonifacino and Traub, 2003). The internalization of
Fpn was reported to be initiated by ligand-induced phosphoryla-
tion on Y302/Y303 residues by JAK2 kinase (De Domenico et al.,
2007, 2009). Despite extensive efforts, we and others (Ross
et al., 2012 [this issue of Cell Metabolism]) have not observed
any evidence of Fpn phosphorylation or involvement of JAK2 in
Fpn endocytosis. We therefore re-examined the mechanisms
for hepcidin-induced Fpn endocytosis.
RESULTS AND DISCUSSION
Hepcidin Binding Triggers Rapid Ubiquitination of Fpn
HEK293 cells stably expressing doxycycline (Dox)-inducible
human Fpn-GFP were treated with hepcidin, and lysates were
immunoprecipitated with an anti-GFP antibody (Ab) and immu-
noblotted with an anti-ubiquitin (Ub) Ab recognizing both poly-
and monoUb (FK2). Fpn-GFP ubiquitination was detected within
10 min after hepcidin treatment and lasted for at least 2 hr (Fig-
ure 1A). Human Fpn-GFP protein is90 kDa, and each Ubmole-
cule is 8.5 kDa. The major ubiquitinated species of Fpn-GFP
migrated in SDS-PAGE with an apparent mass of 130–
180 kDa and so may contain 4–10 Ub molecules, whereas
higher-mass species (250–300 kDa) may contain up to 20–
25 Ubs. To distinguish between polyubiquitination and multimo-
noubiquitination (Figure 1B), we used an Ab recognizing polyUb
only (FK1). FK1 Ab showed a similar pattern of reactivity as the
FK2 Ab, demonstrating that Fpn-GFP was at least polyubiquiti-
nated, but we could not rule out that Fpn may also be mono-
or multimonoubiquitinated. All subsequent Ub blots in themanu-
script were probed with the FK2 Ab. Hepcidin also triggered
rapid and dose-dependent Fpn-GFP ubiquitination in HEK293
cells expressing ponasterone (Pon)-inducible mouse Fpn-GFP
(see Figures S1A and S1B online). Ubiquitination of Fpn was
not an artifact of overexpression, as hepcidin also induced
strong and rapid (within 5 min) ubiquitination of endogenous
Figure 1. Hepcidin Binding Causes Rapid Ubiquitination of Fpn
(A) HEK293 cells stably transfected with a Dox-inducible human Fpn-GFP were either not induced (dox) or induced (+dox) to express Fpn-GFP, then treated
with 1 mg/ml (360 nM) hepcidin for up to 2 hr. Cell lysates were immunoprecipitated with anti-GFP Ab (ab6556) and blotted with anti-poly/monoUb Ab (FK2). The
blot was reprobed with a different anti-GFP Ab (7.1/13.1) to confirm even loading.
(B) Cells were treated identically to those in (A), but the blot was incubated with an Ab recognizing polyUb only (FK1).
(C) Mouse primary bone marrow-derived macrophages were treated with 1 mg/ml hepcidin for up to 1 hr. Lysates were immunoprecipitated with anti-Fpn Ab
(MTP11-A) and immunoblotted with FK2 anti-poly/monoUb Ab. The amount of immunoprecipitated Fpn was verified by probing the blot with another anti-mouse
Fpn Ab (R1).
(D) HEK293 cells stably expressing Dox-inducibleWT Fpn-GFP or C326Smutant which does not bind hepcidin were treated with 1 mg/ml hepcidin and processed
as in (A).
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(BMDMs) (Figure 1C). The apparent mass of Fpn in BMDMs is
65 kDa, whereas ubiquitinated species were about 100–
150 kDa, indicating the attachment4–10 Ub molecules, similar
to overexpressing cell lines.
No hepcidin-dependent ubiquitination was observed in cells
stably expressing an inducible C326S Fpn-GFP mutant which
does not bind hepcidin (Fernandes et al., 2009) (Figure 1D).
The result demonstrated that direct interaction between hepci-
din and Fpn is required for Fpn ubiquitination.
Inhibition of Ubiquitination Prevents Fpn Internalization
Ubiquitination is catalyzed by the sequential action of three
enzymes: E1, E2, and E3. We used PYR-41, an inhibitor of the
Ub-activating enzyme E1, to examine whether blocking ubiquiti-
nation interferes with Fpn internalization. Throughout the study,
the terms ‘‘internalization’’ or ‘‘endocytosis’’ refer to net endocy-
tosis, i.e., detectable redistribution of Fpn from the cell surface to
intracellular compartments. The E1 inhibitor prevented Fpn
endocytosis when it was added together with hepcidin (Fig-
ure S2A). Western blotting with anti-Ub Ab confirmed that the
E1 inhibitor decreased Fpn-GFP ubiquitination (Figure S2B).
These results suggested that Fpn ubiquitination is necessary
for its internalization by hepcidin.
Identification of Fpn Residues Involved in Ubiquitination
To determine which Fpn residues undergo functionally important
ubiquitination, we performed site-directed mutagenesis of Fpn
focusing on regions rich in lysine, the most commonly ubiquiti-
nated amino acid. Human Fpn is thought to have a total of 14
or 15 cytoplasmic lysines (Liu et al., 2005; Rice et al., 2009),Cwith our previous study (Preza et al., 2011) supporting the model
with 14 lysines. Most of the lysines are located in the third intra-
cellular loop (seven or eight lysines, K225 or K229 through K269)
and the C-terminal cytoplasmic segment (three lysines, K549,
K558, and K562) (Figure S3A). The remaining lysines are in the
first (K85, K90), second (K169), and fourth intracellular loops
(K366). Because membrane receptors and transport proteins
are usually ubiquitinated on multiple lysines (Mollah et al.,
2007; Wu et al., 2010; Miranda and Sorkin, 2007), we focused
on the third Fpn intracellular loop and the C terminus. We first
scanned for larger regions involved in ubiquitination by deleting
residues 229–269, 225–247, 247–269, or 549–562. Although
large deletions could alter Fpn-GFP synthesis, localization, or
hepcidin binding, we argued that if hepcidin-induced endocy-
tosis was preserved in any of the mutants, it would allow us to
omit the region from detailed mutagenesis. We transfected the
mutants into HEK293 cells and examined the response to hepci-
din by fluorescent microscopy (Figure S3B). Deletion 549–562
did not interfere with hepcidin-mediated Fpn internalization,
but the deletions in the third intracellular loop did (229–269,
225–247, and partially 247–269). The latter also affected traf-
ficking of Fpn-GFP to the membrane. We then performed less
disruptive mutagenesis of the third intracellular loop by
substituting multiple lysines with arginines. The specific combi-
nations of substitutions were chosen to accommodate the
requirement in multisite-directed mutagenesis for nonoverlap-
ping mutagenesis primers. In transiently transfected HEK293
cells, the K229R/K247R/K269R Fpn-GFP mutant was partially
resistant to hepcidin-mediated internalization (Figure S3B), and
K225R/K240R/K258R and K240/258R mutants were strongly
resistant.ell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc. 919
Figure 2. Lysine Substitutions in the Third Intracellular Loop of Fpn Prevent Hepcidin-Dependent Ubiquitination of Fpn without Affecting
Iron-Exporting Function or Hepcidin Binding
(A) Untransfected HEK293 cells (HEK) and HEK293 stably transfected with Dox-inducible K3R (K229R/K240R/K247R), K4R (K229R/K240R/K247R/K258R), or
DEL (del229–269) Fpn-GFPmutant were incubatedwithout (dox) or with 0.5 mg/ml dox (+dox). After 24 hr, protein lysates were assayed for ferritin levels. Vertical
bars and error bars represent the mean and standard deviation of four to seven experiments. *p = 0.001, **p < 0.001 by t test.
(B) Cells were induced with Dox and treated with 10 mg/ml (3.6 mM) biotinylated hepcidin for 30 min. Protein lysates were immunoprecipitated with anti-GFP Ab
(ab290), and biotinylated hepcidin bound to Fpn-GFP was detected with streptavidin-HRP. The amount of immunoprecipitated Fpn-GFP was determined by
western blotting with anti-GFP Ab (7.1/13.1).
(C) Cells were induced with Dox to expressWT or mutant Fpn-GFP and treated with 1 mg/ml hepcidin for up to 2 hr. Protein lysates were immunoprecipitated with
anti-GFP Ab (ab6556) and immunoblotted with anti-poly/monoUb Ab (FK2) or anti-GFP Ab (7.1/13.1).
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ubiquitination, but this ubiquitination was described as impor-
tant only for Fpn degradation, not internalization (De Domenico
et al., 2007, 2011). We generated a Fpn-GFP mutant that con-
tained the K253R substitution (K236R/K253R) and examined its
ubiquitination after treatment with hepcidin. In contrast to the
published study (De Domenico et al., 2007), the K236R/K253R
mutant was ubiquitinated similarly to WT Fpn-GFP (Figure S4),
indicating that the K253 residue is not the predominant site
for Fpn ubiquitination. Accordingly, the K236R/K253R mutant
internalized normally after hepcidin treatment (Figure S3B).
Analysis of Stably Transfected Lysine Mutants
Transient transfection of cellswith Fpnconstructs is a suboptimal
approach for the study of Fpn function and response to hepcidin
because of the uncontrolled expression of Fpn and cell-to-cell
variability in transfection efficiency. We therefore generated
stably transfected HEK293 cells expressing inducible human
Fpn-GFP (K3R [K229R/K240R/K247R] and K4R [K229R/920 Cell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc.K240R/K247R/K258R]) or the 229–269 deletion. The K2Rmutant
(K240R/K258R) was generated and analyzed independently in
the companion study (Ross et al., 2012). We did not attempt to
mutagenize every lysine in the cytoplasmic Fpn segments,
because the large number of intracellular lysines made the anal-
ysis of possible combinations impractical. Moreover, several
studies indicate that when major lysine sites are mutated, it
can force the ubiquitination of other lysines (Miranda and Sorkin,
2007). Thus, our approach in studying Fpn ubiquitination does
not exclude the possibility that additional cytoplasmic lysines
are important in ubiquitination, but it provides proof-of-principle
evidence for the role of ubiquitination in Fpn internalization by
hepcidin.
We first assessed the iron-exporting function of the stably
transfected Dox-inducible Fpn-GFP mutants by measuring
ferritin as a marker of intracellular iron. Cells expressing K3R or
K4R mutants were iron depleted similarly to wild-type Fpn-
GFP (Figure 2A), indicating that lysine substitutions did not alter
the mutants’ iron-exporting function or plasma membrane
Figure 3. Lysine Substitutions in the Third Intracellular Loop of Fpn Interfere with Hepcidin-Induced Fpn Endocytosis and Cellular Iron
Retention
Stably transfected HEK293 cells were induced with Dox to express WT, K3R, K4R, or del229–269 Fpn-GFP. Dox was washed off prior to adding hepcidin.
(A) Cells were treated with 1 mg/ml (360 nM) hepcidin and Fpn-GFP location assessed at 4 and 24 hr by fluorescent microscopy.
(B) Cells were treatedwith indicated hepcidin concentrations. After 4 hr, cell surface Fpnwas detected by stainingwith anti-human Fpn Ab against an extracellular
loop of Fpn (M1), followed by the secondary Ab conjugated to PE. Fluorescence was quantified by flow cytometry and expressed as percentage fluorescence of
untreated samples. Each point represents the mean and standard deviation of three independent experiments. Each of the mutant curves (K3R, K4R, or DEL)
significantly differed from the WT (p < 0.001, two-way ANOVA).
(C) Cells expressing WT or mutant Fpn-GFP were incubated without or with 0.2 mg/ml (72 nM) hepcidin for 24 hr. Cell lysates were assayed for ferritin. Fold
increase in ferritin after hepcidin treatment is shown as amean and standard deviation of at least six separatemeasurements. *p = 0.003 and **p = 0.001 byMann-
Whitney rank sum test for the comparison of the hepcidin-treated mutant with the hepcidin-treated WT cells. For K3R, K4R, or DEL mutants, no significant
difference in ferritin levels was observed between hepcidin-treated or untreated cells.
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treatment of untransfected HEK293 cells under the conditions
and dose used (0.5 mg/ml) did not cause a measurable change
in cellular iron, as reflected in ferritin levels. The 229–269 deletion
abolished iron export, indicating a disruptive conformational
change or loss of specific residues necessary for the iron-export-
ing function of Fpn.
Hepcidin binding to Fpn depends on several residues in the
extracellular loop 323–343 (Preza et al., 2011). In principle, dele-
tions or substitutions we made could cause hepcidin resistance
not only by decreasing ubiquitination but also by altering the
conformation of the hepcidin-binding loop. To evaluate hepcidin
binding to mutant Fpns, cells were treated with N-terminally bio-
tinylated hepcidin, and its association with Fpn-GFP was deter-
mined by far-western blotting with streptavidin. Biotinylated
hepcidin bound to and migrated with WT Fpn-GFP as expected
(Figure 2B). K3R and K4R Fpn-GFP bound hepcidin similarly to
WT. Hepcidin binding by del229–269 Fpn-GFP was undetect-
able. We used the del229–269 mutant in subsequent experi-
ments as a noninternalizing Fpn-GFP control.CIn contrast to WT Fpn-GFP, hepcidin-dependent ubiquitina-
tion was not observed in any of the mutant Fpns (K3R, K4R
and del229–269) within 2 hr after hepcidin treatment (Figure 2C).
Given that K3R and K4R mutants bind hepcidin normally, some
or all of the lysines that were substituted in these mutants are
required for Fpn ubiquitination.
Ubiquitination of Lysines in the Third Intracellular Loop
of Fpn Is Required for Hepcidin-Induced Fpn
Internalization
We next examined the endocytosis of K3R, K4R, and del229–
269 Fpn mutants after treatment with hepcidin. Fluorescent
microscopy showed that, in contrast toWT Fpn-GFPwhich inter-
nalized readily upon hepcidin addition, K3R and K4R mutants
remained at the cell surface at 4 hr (Figure 3A). After 24 hr, these
mutants underwent partial internalization and degradation but
much less than WT Fpn-GFP. The partial endocytosis suggests
that additional lysine residues may become ubiquitinated, or
another mechanism becomes important. Del229–269 mutant
had mostly plasma membrane localization even after 24 hr.ell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc. 921
Figure 4. K240E Human Fpn Mutation Causes Hepcidin Resistance
(A) Stably transfected HEK293 cells were inducedwith Dox to expressWT or K240E Fpn-GFP andwere treatedwith 1 mg/ml hepcidin for up to 2 hr. Protein lysates
were immunoprecipitated with anti-GFP Ab (ab6556) and immunoblotted with anti-poly/monoUb Ab (FK2) or anti-GFP Ab (7.1/13.1).
(B) HEK293 cells induced to express WT or K240E Fpn-GFP were treated with 1 mg/ml hepcidin and Fpn-GFP location assessed after 4 and 24 hr by fluorescent
microscopy. WT images are identical to those in Figure 3A.
(C) HEK293 cells induced to express WT or K240E Fpn-GFP were treated with 0.2 mg/ml hepcidin for the indicated time. To quantify cell surface Fpn, cells were
stained with anti-human Fpn Ab against an extracellular loop of Fpn (M1), followed by the secondary Ab conjugated to PE. Fluorescence was measured by flow
cytometry and results expressed as percentage of the fluorescence of untreated samples. Means and standard deviations of four separate measurements are
shown. K240E and WT were compared at each time point by t test.
(D) Cells expressingWT or K240E Fpn-GFPwere incubated without or with 0.2 mg/ml hepcidin for 24 hr, and protein lysates were assayed for ferritin (n = 10 for WT
and 12 for K240E). WT values are the same as in Figure 3C. The means and standard deviations of fold increase in ferritin levels after hepcidin treatment are
shown, p = 0.003 by Mann-Whitney rank sum test for the comparison of the hepcidin-treated K240E with the hepcidin-treated WT cells.
(E) Shown is serum hepcidin, ferritin, and hepcidin/ferritin ratio in two subjects with K240E mutation, compared to historical controls (Ganz et al., 2008).
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tion of increasing hepcidin concentration using flow cytometry of
live cells stained with an Ab to an extracellular Fpn loop (M1).
Hepcidin caused an expected dose-dependent decrease in
cell surface WT Fpn-GFP (Figure 3B), whereas K3R and K4R
mutations interfered with Fpn-GFP internalization, particularly
at lower hepcidin concentrations (p < 0.001 for each mutant
versus WT by two-way ANOVA). As expected, del229–269 was
completely resistant to internalization.
Decreased internalization of Fpn should allow greater cellular
iron export. Indeed, measurement of intracellular ferritin concen-
trations showed that in contrast to the iron retention in hepcidin-
treated cells expressing WT Fpn-GFP, K3R and K4R Fpn-GFP
continued exporting iron in the presence of hepcidin (Figure 3C).
The results confirmed the importance of lysine residues in
segment 229–269 for hepcidin-mediated Fpn internalization.
The specific details of Fpn endocytic sorting, including which
Ub-binding adaptor proteins may be involved, remain to be
determined.
K240E Substitution in Humans: A Case of Hepcidin
Resistance?
A patient with mild iron overload was reported to be heterozy-
gous for two mutations, c.-20G > A in HFE and p.K240E in Fpn922 Cell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc.(Del-Castillo-Rueda et al., 2011), and we hypothesized that
K240E substitution could be causing ferroportin resistance to
hepcidin. We examined the effect of K240E substitution
in vitro in stably transfected HEK293 cells expressing Dox-
inducible K240E Fpn-GFP. In comparison to WT Fpn-GFP,
ubiquitination of K240E mutant was considerably diminished
(Figure 4A). The mutant also had a defect in hepcidin-induced
endocytosis. Fluorescent microscopy 4 hr after hepcidin addi-
tion revealed that more K240E Fpn-GFP protein remained on
the cell surface compared to WT (Figure 4B), and at 24 hr
the K240E mutant was less degraded than WT Fpn-GFP.
Quantitation of cell surface Fpn by flow cytometry confirmed
the delay in hepcidin-induced endocytosis of K240E Fpn-
GFP (Figure 4C). Furthermore, as assessed by ferritin assay,
cells expressing K240E Fpn-GFP were partially resistant to
hepcidin-mediated iron retention (Figure 4D). Thus, decreased
hepcidin-mediated ubiquitination and decreased endocytosis
of Fpn due to K240E substitution could cause partial resistance
to hepcidin and mild iron overload. Unlike patients with HFE
mutations (Piperno et al., 2007), the proband shows features
of resistance to hepcidin, with hepcidin levels that were above
the median hepcidin concentration of healthy historical
controls (Ganz et al., 2008), and a normal hepcidin/ferritin ratio
(Figure 4E). His daughter, also heterozygous for the K240E
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unusual for young women even when carrying hemochroma-
tosis-causing mutations (Laine et al., 2005). We therefore
propose that the mild iron overload in the proband could result
from the effect of K240E substitution on ferroportin internaliza-
tion by hepcidin.
Several other human mutations have been reported in the
third intracellular loop of Fpn. D270V (Zaahl et al., 2004) was
associated with mild clinical iron overload and phenotype
resembling hepcidin resistance (elevated transferrin saturation
and serum iron), whereas G267D (Cremonesi et al., 2005) and
polymorphism Q248H (Gordeuk et al., 2003) were associated
with elevated serum ferritin but normal serum iron, similar to
classical Fpn disease due to loss of Fpn function. Because
amino acids proximal to lysine residues are critical for control-
ling the efficiency of lysine ubiquitination (Sadowski and Sar-
cevic, 2010), it is possible that these mutations could cause
iron disturbances by decreasing or increasing the efficiency of
Fpn ubiquitination.
Conclusions
Molecular mechanism of hepcidin-mediated Fpn endocytosis
was previously reported to involve phosphorylation of Y302/
Y303 residues by JAK2 kinase (De Domenico et al., 2007,
2009). However, together with the companion study by Ross
et al. (2012), we now provide a comprehensive revision of the
mechanism of hepcidin-induced Fpn endocytosis. Although we
used reagents and experimental setup similar to those of
De Domenico et al., including Pon-inducible mouse WT Fpn-
GFP cell line (Nemeth et al., 2004) and transient transfection of
Fpn-GFP mutants into HEK293 cells, we were unable to repro-
duce their previously reported findings. We also verified the
effects of Fpn mutations in stably transfected cells expressing
Dox-inducible mutants, a system in which the effects of muta-
tions are less confounded by cell-to-cell variability than in tran-
sient transfections. The discrepancy in the results will require
further investigation.
Ross et al. (2012) demonstrated that Fpn is not phosphory-
lated after hepcidin binding, and that neither Y302/Y303 resi-
dues nor JAK2 is necessary for Fpn internalization. Our study
instead showed that ubiquitination is the signal required for
Fpn endocytosis after hepcidin binding. Hepcidin triggered Fpn
polyubiquitination in cells overexpressing Fpn-GFP (both Pon-
and Dox-inducible) as well as in primary mouse BMDMs. Substi-
tutions of lysines in the third intracellular loop of Fpn ablated
ubiquitination, greatly retarded hepcidin-induced Fpn endocy-
tosis, and promoted cellular iron export despite the presence
of hepcidin. It is not yet clear whether the observed pattern of
Fpn ubiquitination also directs Fpn trafficking to lysosomes
where Fpn is degraded (Nemeth et al., 2004).
The hepcidin-Fpn axis plays a pathogenic role in multiple iron
disorders. Thus, modulating Fpn internalization is a potential
therapeutic target. Ubiquitination, however, regulates a broad
spectrum of biological processes, and the feasibility of any phar-
macological interventions would depend on achieving high
target specificity, perhaps by generating specific inhibitors of
the E3 ubiquitin ligase(s) involved in Fpn endocytosis. More
detailed examination of the molecular mechanisms regulating
Fpn ubiquitination and endocytosis is therefore warranted.CEXPERIMENTAL PROCEDURES
Site-Directed Mutagenesis
Human Fpn-GFP in pGFP-N3 vector (Fernandes et al., 2009) was used as the
template for site-directed mutagenesis. Deletions, single mutations, or
multiple mutations were introduced using QuikChange II XL and Lightning
Multi Site-Directed Mutagenesis kits (Agilent Technologies, Santa Clara,
CA) and confirmed by sequencing. Mutagenesis primers are listed in
Table S1.
Transient Transfection and Microscopy
Fpn-GFP plasmids were transiently transfected into HEK293T cells using
either Lipofectamine 2000 (Invitrogen, Carlsbad CA) or Amaxa nucleofection
(Lonza, Walkersville, MD). In transiently transfected cells, the endocytic
effect of hepcidin on Fpn can be obscured by the continuous high rate of
Fpn-GFP production. Therefore, cells were treated with 50 mg/ml cyclohexi-
mide for 2 hr to slow down Fpn-GFP synthesis before hepcidin addition.
Cells were visualized with an epifluorescence microscope (Nikon Eclipse,
Melville, NY), and images were acquired with a 403 objective, SPOT camera,
and SPOT Advanced Imaging Software (Diagnostic Instruments, Sterling
Heights, MI).
Stably Transfected Cell Lines
Human WT and mutant K3R, K4R, K240E, del229–269, and C326S Fpn-GFP
constructs were cloned into pLVX-Tight-Puro lentiviral vector (Clontech,
Mountain View, CA) and verified by sequencing. Following viral packaging
(UCLA Vector Core facility), Tet-on Advanced HEK293 cells (Clontech) were in-
fected, and colonies were selected in the presence of 3 mg/ml puromycin and
100 mg/ml G418 for 3 weeks. Dox (Sigma, St. Louis, MO) was used to induce
expression of Fpn-GFP. For some experiments, we also used HEK293 cells
expressing Pon-inducible mouse Fpn-GFP (Nemeth et al., 2004). Hepcidin
was purchased from Peptides International (Louisville, KY) and E1 enzyme
inhibitor PYR-41 from Calbiochem (San Diego, CA).
Primary Murine Macrophage Culture
BMDMswere isolated frommouse femurs and grown in DMEMwith 10%heat-
inactivated fetal calf serum and 20% L-cell-conditioned medium for 7 days. To
increase endogenous Fpn, cells were incubated with Fe-NTA (100 mM FeCl3,
400 mM NTA) for 20 hr. Animal studies were approved by the UCLA Animal
Research Committee.
Immunoprecipitation and Western Blotting
Proteins were extracted with RIPA buffer supplemented with protease inhib-
itor cocktail. Fpn-GFP was immunoprecipitated with anti-GFP rabbit poly-
clonal Ab (ab6556 or ab290, Abcam, Cambridge, MA) and endogenous
BMDM Fpn with anti-mouse Fpn antibody (MTP-11A, ADI, San Antonio, TX).
For western blotting, primary antibodies included the following: anti-Ubmono-
clonal antibodies FK1 and FK2 (Enzo Life Sciences, Farmingdale, NY), both at
1 mg/ml final concentration; anti-GFP mouse monoclonal antibody (0.4 mg/ml,
clones 7.1/13.1, Roche, Indianapolis, IN); and rat anti-mouse Fpn antibody
(1–2 mg/ml R1, Ab description provided in the Supplement). Chemilumines-
cent signal was detected using ChemiDoc XRS+ System with Image Lab Soft-
ware (Bio-Rad).
Hepcidin Binding Assay
Cells were treated with 10 mg/ml N-terminally biotinylated hepcidin
(Peptides International) for 30 min at 37C. Protein lysates were immunopre-
cipitated with anti-GFP Ab and blotted with Streptavidin-HRP (Pierce, Rock-
ford, IL).
Ferritin Assay
Cellular ferritin was assayed by ferritin ELISA (Ramco Laboratories, Stafford,
TX) and normalized to the total protein concentration in each sample, as deter-
mined by the BCA assay.
Flow Cytometry
Fpn-GFP cell lines were induced with Dox and treated with hepcidin. Cells
were then detached with TrypLE (Invitrogen), incubated with primary antibodyell Metabolism 15, 918–924, June 6, 2012 ª2012 Elsevier Inc. 923
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Ross et al., [2012] companion manuscript), and secondary antibody conju-
gated to PE. Fluorescence was quantified by flow cytometry at UCLA Jonsson
Comprehensive Cancer Center and Center for AIDS Research Flow Cytometry
Core Facility.
Serum Hepcidin and Ferritin Measurement
Serum hepcidin was measured by competitive ELISA at Intrinsic LifeSciences
LLC (Ganz et al., 2008), and serum ferritin was measured by the Clinical Labo-
ratory at Hospital General Universitario Gregorio Maranon.
Statistical Analysis
Statistical analysis employed the t test (normally distributed data), Mann-Whit-
ney rank sum test (data with nonnormal distribution), and two-way ANOVA
(comparison of groups) (SigmaPlot version 11.0, Systat Software). The error
bars in the figures represent standard deviations of the indicated number of
experiments.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at doi:10.1016/j.cmet.2012.03.018.
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